Faculty & Research
Faculty & research are integral components of BME. With a strong focus on research, BME is located in the heart of Canada’s largest health-care research hub. Our graduate students receive their training from 14 departments at U of T, 10 partner hospitals, and 7 research institutes & commercialization centres.
At BME, our cross-disciplinary approach in biomedical and clinical engineering enables our researchers to cover a diverse set of topics. Find out what our research publication are saying about our research focus.
Quick Navigation
Faculty directory
Core Faculty
We have 30+ core faculty members that span across cell & tissue engineering, clinical engineering, and molecular engineering disciplines.
Cross-Appointed Faculty
BME currently hosts cross-appointed faculty members across more than 30 academic units, partner hospitals, research institutes, and commercialization centres.
Emeriti
Learn about some of our retired faculty members
Research streams
Clinical
BME’s clinical engineers design technologies, devices and strategies for people with chronic disease, traumatic injury, disabilities and mobility limitations to help them integrate more fully with their environment.
Cell & Tissue
Research that has the potential to change how we think about disease and aging is happening at BME. Regenerative medicine uses stem cells and biomaterials to repair, replace or regenerate damaged tissue, organ structures and function.
Molecular
BME researchers are advancing disease detection, customizing drug delivery and improving health-care outcomes with faster and more precise technologies and systems.
Latest news
Professor Freeman Lan Awarded Federal NFRF Grant to Advance Rapid Infection Diagnostics
Professor Freeman Lan has been awarded a $250,000 grant through the Government of Canada’s New Frontiers in Research Fund (NFRF) to support a project aimed at transforming how infectious diseases are diagnosed and treated.
U of T Engineering professor honoured nationally for excellence in training Canada’s next generation of regenerative medicine leaders
Professor Milica Radisic has been named a recipient of the Talent Builder Award as part of the Stem Cell Network’s 25 for 25 Silver Anniversary Awards, a national initiative recognizing 25 individuals and organizations whose contributions have shaped Canada’s regenerative medicine ecosystem over the past 25 years.
Two BME professors receive 2026 Connaught Innovation Awards
Two professors from the University of Toronto Institute of Biomedical Engineering have received 2026 Connaught Innovation Awards, a competitive internal research funding program. Professors Paul Yoo and Daniel Franklin are among 14 award recipients selected this year for innovations with strong potential for societal impact.
Improving rehabilitation through neurotechnology | José Zariffa Lab
At the Adaptive Neurorehabilitation Systems Lab, Professor Jose Zariffa and his team are developing technologies to support recovery after spinal cord injury and stroke. Using wearable sensors, neural interfaces, deep learning, and computer vision, the lab studies movement and nervous system activity to improve rehabilitation therapies and assistive technologies.
Professor Luka Milosevic awarded $1.65 million NSERC CREATE grant to advance neuromodulation training
Professor Luka Milosevic awarded $1.65 million NSERC CREATE grant to advance neuromodulation training Professor Luka Milosevic has received a $1.65 million […]
Tiny immune cell particles help blood vessels grow in lab-made human heart tissue
University of Toronto researchers (left: Karl Wagner, right: Milica Radisic) found that tiny particles released by immune cells help blood vessels form in lab grown human heart tissue, offering new insights into heart repair and tissue engineering.
Faculty startups
The following list highlights some of the startup companies that have been launched by these forward-thinking faculty members, demonstrating their commitment to translating academic knowledge into real-world applications and making a significant impact on the biomedical industry.
| Faculty Member | Commercialization Venture | Focus | Location |
|---|---|---|---|
| Jan Andrysek | LegWorks | Prosthetic Knee Joint | San Francisco |
| John E. Davies | Tissue Regenerative Therapeutics Inc. | Mesenchymal Stem Cells | Toronto |
| Milos Popovic | MyndTech Inc. | Medical Tech Company | Mississauga |
| Milica Radisic | Tara Biosystems | Cardiac Drug Discovery | New York |
| Jonathan Rocheleau | QuantM3 | Microfluidics Technology Diabetes Treatment | Toronto |
| Paul Santerre | Interface Biologics | Drug Delivery and other technologies | Toronto |
| Paul Santerre and Eli Sone | Cohesys Inc | Bone Tape to replace plate and screws in craniofacial repair; Angel investment | Toronto |
| Paul Santerre | Ripple Therapeutics | Non-polymeric anti-inflammatory drug delivery systems for ophthalmology; venture invested | Toronto |
| Molly Shoichet | AmacaThera | Injectable hydrogel platform technology | Toronto |
| Aaron Wheeler | Miroculus (formerly Kappex) | Digital Microfluidics Platform | Toronto |